nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—HTR2A—conduct disorder	0.924	1	CbGaD
Buspirone—DRD3—Dopamine receptors—DRD4—conduct disorder	0.00774	0.102	CbGpPWpGaD
Buspirone—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00592	0.0781	CbGpPWpGaD
Buspirone—HTR2B—Serotonin receptors—HTR2A—conduct disorder	0.00269	0.0355	CbGpPWpGaD
Buspirone—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00246	0.0324	CbGpPWpGaD
Buspirone—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.00218	0.0288	CbGpPWpGaD
Buspirone—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00188	0.0248	CbGpPWpGaD
Buspirone—HTR2B—Monoamine GPCRs—DRD4—conduct disorder	0.00184	0.0242	CbGpPWpGaD
Buspirone—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.00179	0.0236	CbGpPWpGaD
Buspirone—DRD3—Monoamine GPCRs—DRD4—conduct disorder	0.00171	0.0225	CbGpPWpGaD
Buspirone—HTR2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.00155	0.0204	CbGpPWpGaD
Buspirone—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.00149	0.0196	CbGpPWpGaD
Buspirone—DRD3—Amine ligand-binding receptors—DRD4—conduct disorder	0.00144	0.0189	CbGpPWpGaD
Buspirone—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00134	0.0177	CbGpPWpGaD
Buspirone—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00131	0.0172	CbGpPWpGaD
Buspirone—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.00129	0.017	CbGpPWpGaD
Buspirone—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00125	0.0165	CbGpPWpGaD
Buspirone—HTR2B—Monoamine GPCRs—HTR2A—conduct disorder	0.0012	0.0158	CbGpPWpGaD
Buspirone—DRD3—Monoamine GPCRs—HTR2A—conduct disorder	0.00112	0.0147	CbGpPWpGaD
Buspirone—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0011	0.0145	CbGpPWpGaD
Buspirone—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00108	0.0143	CbGpPWpGaD
Buspirone—HTR2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00101	0.0133	CbGpPWpGaD
Buspirone—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.000973	0.0128	CbGpPWpGaD
Buspirone—DRD3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000938	0.0124	CbGpPWpGaD
Buspirone—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000854	0.0113	CbGpPWpGaD
Buspirone—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000817	0.0108	CbGpPWpGaD
Buspirone—DRD3—GPCRs, Other—DRD4—conduct disorder	0.00076	0.01	CbGpPWpGaD
Buspirone—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000718	0.00946	CbGpPWpGaD
Buspirone—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000678	0.00893	CbGpPWpGaD
Buspirone—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000653	0.00861	CbGpPWpGaD
Buspirone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000597	0.00787	CbGpPWpGaD
Buspirone—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000572	0.00754	CbGpPWpGaD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000543	0.00715	CbGpPWpGaD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000505	0.00666	CbGpPWpGaD
Buspirone—DRD3—GPCRs, Other—HTR2A—conduct disorder	0.000496	0.00653	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000458	0.00603	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00044	0.0058	CbGpPWpGaD
Buspirone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000432	0.00569	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—SLC6A4—conduct disorder	0.000429	0.00565	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—CGA—conduct disorder	0.000413	0.00545	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—DRD4—conduct disorder	0.000403	0.00531	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000395	0.00521	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000386	0.00509	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—CGA—conduct disorder	0.000385	0.00507	CbGpPWpGaD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00038	0.00501	CbGpPWpGaD
Buspirone—DRD3—G alpha (i) signalling events—DRD4—conduct disorder	0.000356	0.00469	CbGpPWpGaD
Buspirone—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000355	0.00468	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000344	0.00454	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000335	0.00442	CbGpPWpGaD
Buspirone—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00033	0.00435	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000328	0.00432	CbGpPWpGaD
Buspirone—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00032	0.00421	CbGpPWpGaD
Buspirone—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.000317	0.00418	CbGpPWpGaD
Buspirone—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.000315	0.00415	CbGpPWpGaD
Buspirone—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.00031	0.00409	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000308	0.00406	CbGpPWpGaD
Buspirone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000307	0.00405	CbGpPWpGaD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000304	0.00401	CbGpPWpGaD
Buspirone—HTR2B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000299	0.00395	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000297	0.00392	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000294	0.00388	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.00029	0.00382	CbGpPWpGaD
Buspirone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000288	0.00379	CbGpPWpGaD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000283	0.00373	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000281	0.0037	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000272	0.00359	CbGpPWpGaD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000268	0.00353	CbGpPWpGaD
Buspirone—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000253	0.00333	CbGpPWpGaD
Buspirone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000248	0.00328	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000246	0.00325	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000234	0.00308	CbGpPWpGaD
Buspirone—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000231	0.00305	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000231	0.00305	CbGpPWpGaD
Buspirone—CYP3A5—Biological oxidations—COMT—conduct disorder	0.000231	0.00304	CbGpPWpGaD
Buspirone—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.000229	0.00302	CbGpPWpGaD
Buspirone—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.000228	0.003	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000217	0.00286	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000216	0.00285	CbGpPWpGaD
Buspirone—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000215	0.00284	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000215	0.00284	CbGpPWpGaD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000213	0.00281	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.000212	0.0028	CbGpPWpGaD
Buspirone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000201	0.00265	CbGpPWpGaD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000198	0.00261	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000197	0.0026	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000189	0.0025	CbGpPWpGaD
Buspirone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000188	0.00247	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000188	0.00247	CbGpPWpGaD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000184	0.00243	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000172	0.00227	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000166	0.00219	CbGpPWpGaD
Buspirone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000165	0.00217	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000165	0.00217	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000164	0.00216	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000164	0.00216	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000163	0.00215	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000162	0.00214	CbGpPWpGaD
Buspirone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000162	0.00214	CbGpPWpGaD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000161	0.00212	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000161	0.00212	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000151	0.00199	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	0.000151	0.00199	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000149	0.00196	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000149	0.00196	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000141	0.00186	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—HTR2A—conduct disorder	0.00014	0.00185	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—EP300—conduct disorder	0.000139	0.00184	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000132	0.00174	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	0.000131	0.00172	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000128	0.00169	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CGA—conduct disorder	0.000125	0.00165	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000122	0.00161	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—DRD4—conduct disorder	0.000122	0.0016	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CGA—conduct disorder	0.000121	0.0016	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—DRD4—conduct disorder	0.000119	0.00157	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CGA—conduct disorder	0.000117	0.00154	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—DRD4—conduct disorder	0.000111	0.00146	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000108	0.00142	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000107	0.00142	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000107	0.00141	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000107	0.00141	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.000106	0.0014	CbGpPWpGaD
Buspirone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000106	0.0014	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CGA—conduct disorder	0.000102	0.00134	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—WASF1—conduct disorder	0.0001	0.00132	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—DRD4—conduct disorder	9.63e-05	0.00127	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—WASF1—conduct disorder	9.34e-05	0.00123	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—DRD4—conduct disorder	9.31e-05	0.00123	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	9.16e-05	0.00121	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CGA—conduct disorder	8.92e-05	0.00118	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CGA—conduct disorder	8.78e-05	0.00116	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CGA—conduct disorder	8.75e-05	0.00115	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	8.53e-05	0.00112	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—DRD4—conduct disorder	8.46e-05	0.00111	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—DRD4—conduct disorder	8.32e-05	0.0011	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—WASF1—conduct disorder	8.14e-05	0.00107	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	7.94e-05	0.00105	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	7.75e-05	0.00102	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HTR2A—conduct disorder	7.21e-05	0.00095	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—WASF1—conduct disorder	7.15e-05	0.000942	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—WASF1—conduct disorder	7.03e-05	0.000927	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—DRD4—conduct disorder	7.02e-05	0.000925	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	6.92e-05	0.000912	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	6.87e-05	0.000906	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CGA—conduct disorder	6.6e-05	0.00087	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—DRD4—conduct disorder	6.53e-05	0.00086	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	6.28e-05	0.000828	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CGA—conduct disorder	6.22e-05	0.00082	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	6.08e-05	0.000801	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—DRD4—conduct disorder	5.69e-05	0.00075	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HTR2A—conduct disorder	5.52e-05	0.000727	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—COMT—conduct disorder	5.46e-05	0.00072	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—MAOA—conduct disorder	5.43e-05	0.000715	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—DRD4—conduct disorder	5e-05	0.000658	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.91e-05	0.000648	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HTR2A—conduct disorder	4.58e-05	0.000603	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HTR2A—conduct disorder	4.26e-05	0.000561	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CGA—conduct disorder	4.07e-05	0.000536	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—COMT—conduct disorder	3.95e-05	0.000521	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—MAOA—conduct disorder	3.92e-05	0.000517	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HTR2A—conduct disorder	3.71e-05	0.000489	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.26e-05	0.00043	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—COMT—conduct disorder	2.98e-05	0.000393	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—MAOA—conduct disorder	2.96e-05	0.00039	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—COMT—conduct disorder	2.81e-05	0.00037	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—MAOA—conduct disorder	2.79e-05	0.000368	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EP300—conduct disorder	2.43e-05	0.00032	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—EP300—conduct disorder	2.34e-05	0.000309	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EP300—conduct disorder	2.26e-05	0.000297	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EP300—conduct disorder	1.97e-05	0.000259	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—COMT—conduct disorder	1.84e-05	0.000242	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—MAOA—conduct disorder	1.82e-05	0.00024	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EP300—conduct disorder	1.73e-05	0.000228	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EP300—conduct disorder	1.7e-05	0.000224	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—EP300—conduct disorder	1.69e-05	0.000223	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—EP300—conduct disorder	1.28e-05	0.000168	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—EP300—conduct disorder	1.2e-05	0.000159	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—EP300—conduct disorder	7.88e-06	0.000104	CbGpPWpGaD
